Skip to content
Menu
Seyda CASKURLU
  • SC Life Sciences
  • About Me
  • News & Updates
Seyda CASKURLU

Month: March 2019

“Beauty and the Beast”​ Turkey Pharmaceutical Market SWOT Final Part

Posted on 27/03/201927/03/2019

And now it’s time to share Beauty and the Beast’s final version. To comprehend the Turkish Pharmaceutical Market potential completely, it might be valuable to review “opportunities and threads” together after ranking strengths and weaknesses of the industry individually. Turkey, with its refugee inflated >82MM population (TUIK/2018), has a statistically good potential vs. its peers among OECD countries with its current…

7 Drugs Expected to Be Blockbusters by 2023

Posted on 25/03/201925/03/2019

Biospace shared the summary of Clarivate Analytics’ report “Cortellis Drugs to Watch,” in which seven new drugs identified as blockbusters by 2023, here is the list; #1. AbbVie’s Upadacitinib. On December 20, 2018, AbbVie submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA)and a marketing authorization application (MAA) to the European Medicines Agency (EMA)for…

placebo? nocebo?…

Posted on 02/03/201902/03/2019
  • info@seydacaskurlu.com
©2025 Seyda CASKURLU | Powered by SuperbThemes & WordPress